Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–8 of 8 results
Advanced filters: Author: Guy Bate Clear advanced filters

    • Mayer B. Davidson
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 4, P: 713-714

  • Tipranavir (Aptivus; Boehringer Ingelheim) was given accelerated approval by the FDA for the treatment of HIV-1 infection in combination with other antiretroviral agents in June 2005. It is the first in a new class of non-peptidic HIV-1 protease inhibitors, and is active against HIV-1 strains that are resistant to other protease inhibitors.

    • Charles Flexner
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 4, P: 955-956

    • Anthony Schapira
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 4, P: 625-626

    • Daniel Buysse
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 4, P: 881-882

    • Larry Moreland
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 5, P: 185-186

    • John J. Hopwood
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 5, P: 101-102

    • Varsha Gandhi
    • Michael J. Keating
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 5, P: 17-18

    • Richard Wenzel
    • Guy Bate
    • Peter Kirkpatrick
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 4, P: 809-810